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Abstract:
Aim:  The oncological risk/benefit trade-off for laparoscopy in rectal 
cancer is controversial. Our aim was to compare laparoscopic versus 
open surgery for resection of rectal cancer, using real-world data from 
the public healthcare system of Catalonia (Spain). 
Methods: Multicentre retrospective cohort study of all non-metastatic 
patients who underwent surgery with a curative intent for primary rectal 
cancer at Catalonian public hospitals in 2011-2012. We obtained data on 
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vital status for up to five years. To minimise differences between the two 
groups we performed propensity score matching on baseline patient 
characteristics. We used multivariate Cox proportional hazards 
regression analyses to assess locoregional relapse at two years and 
death at two and five years. 
Results: Of 1513 patients with stage I to III rectal cancer, 933 (61.7%) 
underwent laparoscopy (conversion rate: 13.2%).  After applying our 
propensity score matching strategy (2:1), 842 laparoscopy patients were 
matched to 517 open surgery patients. Multivariate Cox analysis of death 
at two years (hazard ratio [HR] 0.65; 95% confidence interval [CI] 0.48, 
0.87; p=0.004) and five years (HR 0.61; 95% CI 0.5, 0.75. p <0.001) 
and of local relapse at two years (HR 0.44; 95% CI 0.27, 0.72; 
p=0.001) showed laparoscopy to be an independent protective factor 
compared to open surgery.                                                                   
                                                                                                          
                                                                                        
Conclusions: Laparoscopy results in lower locoregional relapse and long-
term mortality in rectal cancer in real-world conditions with all-risk 
patient groups included. Studies using long-term follow-up of cohorts 
and real-world data can provide information on clinically relevant 
outcomes to supplement randomized controlled trials. 
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ABTRACT
Aim:  The oncological risk/benefit trade-off for laparoscopy in rectal cancer is controversial. Our aim was to 
compare laparoscopic versus open surgery for resection of rectal cancer, using real-world data from the 
public healthcare system of Catalonia (Spain).
Methods: Multicentre retrospective cohort study of all non-metastatic patients who underwent surgery 
with a curative intent for primary rectal cancer at Catalonian public hospitals in 2011-2012. We obtained 
data on vital status for up to five years. To minimise differences between the two groups we performed 
propensity score matching on baseline patient characteristics. We used multivariate Cox proportional 
hazards regression analyses to assess locoregional relapse at two years and death at two and five years.
Results: Of 1513 patients with stage I to III rectal cancer, 933 (61.7%) underwent laparoscopy (conversion 
rate: 13.2%).  After applying ur propensity score matching strategy (2:1), 842 laparoscopy patients were 
matched to 517 open surgery patients. Multivariate Cox analysis of death at two years (hazard ratio [HR] 
0.65; 95% confidence interval [CI] 0.48, 0.87; p=0.004) and five years (HR 0.61; 95% CI 0.5, 0.75. p <0.001) 
and of local relapse at two years (HR 0.44; 95% CI 0.27, 0.72; p=0.001) showed laparoscopy to be an 
independent protective factor compared to open surgery.                                                                                                                                                                                                                                                                     
Conclusions: Laparoscopy results in lower locoregional relapse and long-term mortality in rectal cancer in 
real-world conditions with all-risk patient groups included. Studies using long-term follow-up of cohorts 
and real-world data can provide information on clinically relevant outcomes to supplement randomized 
controlled trials. 
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What does this paper add to the literature?
The oncological risk/benefit trade-off for laparoscopy in rectal cancer is controversial. We compare laparoscopic 
versus open surgery for treating primary rectal cancer, using population-based data plus propensity score analysis to 
improve comparability. The results provide further evidence in favour of laparoscopy as a standard surgical 
approach, in real-world conditions. 
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Introduction
Surgery is the cornerstone therapy for non-metastatic rectal cancer. In the past two decades, substantial 
improvements in both rectal surgery (standardization of mesorectal excision) and perioperative 
management (preoperative chemoradiotherapy and postoperative chemotherapy for locally advanced 
rectal cancer) have contributed to reducing the risk of local recurrence [1–3]. Efforts have also been made 
to decrease the risk of postoperative morbidity and improve functional outcomes [4,5]. Minimally invasive 
surgical approaches including laparoscopy have been introduced to further improve surgical management 
in patients with rectal cancer [6–8]. In this respect, the laparoscopic approach has demonstrated clinically 
measurable short-term advantages in rectal cancer [9,10]. However, unlike in surgery for colon cancer, 
there is still controversy regarding the oncological safety of laparoscopy in rectal cancer surgery: while 
several trials, meta-analyses and observational studies comparing short- and long-term outcomes between 
laparoscopic and open surgery have supported the oncological safety of a minimally invasive approach in 
these patients [11–16], one recent systematic review questioned the capacity to achieve a successful 
resection of rectal cancer [17].
In Catalonia (Spain), the surgical treatment of rectal cancer has been centralized since 2012 in order to 
improve equitable access to quality multidisciplinary care. The policy of concentrating tertiary surgical 
activity has been accompanied by regular evaluations of rectal cancer surgery through clinical audits [18]. 
The 2011–12 clinical audit on rectal cancer included information on laparoscopic surgery. 
The aim of the present study was to compare process and outcomes indicators of laparoscopic versus open 
surgery for surgical treatment of rectal cancer, using real-world data from the public healthcare system of 
Catalonia at two and five years’ follow-up.
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Methods
We conducted a multicenter retrospective cohort study of all rectal cancer patients who were surgically 
treated for the first time with curative intent in public hospitals of Catalonia in 2011 and 2012, followed up 
until 2017 for five-year survival. We excluded all patients who had a tumor located outside the rectum (> 
15 cm from anal margin), patients who had preneoplastic diseases or who did not receive surgery for their 
primary tumor during the study period. We also excluded patients who underwent surgery with palliative 
intent and patients with stage IV disease at diagnosis. The methodology used for identifying cases and 
retrieving data was the same as with the previous audit, involving trained external auditors; the details are 
described in length elsewhere [19]. The Clinical Research Ethics Committee of Bellvitge University Hospital 
approved this study.
The main variable of interest in this the study was surgical approach (laparoscopic versus open surgery). 
Comparisons between the two groups followed the intention-to-treat principle by including converted 
resections in the laparoscopic group [9,15,16]. In order to determine whether conversion was a risk factor, 
we also performed a subgroup analysis in the conversion group [20].
We collected data on comorbidities from the Catalonian hospital discharge minimum data set from 2003 to 
date of admission for surgery, adding the information to each patient’s records. This data set was 
processed through the ASEDAT software for cancer registry automation, which allowed data extraction 
[21]. Excluding all types of solid tumor cancer and metastases, comorbidities were categorized according to 
the number of pathologies affecting the patient at the time of surgery (none, 1, 2+, unknown)[22]. 
Tumors were classified according to the distance between the tumor and the anal margin and the 
anatomical extent of the disease (TNM Classification of Malignant Tumors, 7th edition) as recorded in the 
diagnostic procedures report (tumor location, cT, cN). The anatomical pathology report provided data on 
the pT (TNM 7th edition), the mesorectal excision (complete, almost complete or incomplete), the radial 
margin (positive [≤ 1 mm] or not), and the number of lymph nodes examined.
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Time to last follow-up, locoregional recurrence, metastasis and death were assessed from the date of 
rectal excision.  We performed a linkage with the central registry of the insured population of Catalonia in 
order to update the vital status of all participants up to five years, until February 2017. Locoregional 
recurrence was defined as any tumor located within the pelvis, either alone or with metastases, and 
confirmed histologically or by imaging. Systemic recurrence was defined as spread of the disease outside 
the surgical field to organs such as the liver, lungs, bones or brain.
Statistical analysis
First, we performed a descriptive analysis of the categorical variables using absolute and relative 
frequencies. Next, we compared the study variables by surgical approach using the Chi-squared test and 
Student T-test. Death rates were also calculated at five years’ follow-up. 
Propensity score matching 
To minimize baseline differences between the open surgery group and the laparoscopy group, we 
undertook propensity score matching (PSM)(23), which consists of the estimated probability for a patient 
to be in the open surgery group based on clinical characteristics. We matched two individuals in the 
laparoscopic group (laparoscopy + conversion) to each individual in the open surgery group. Confounding 
variables used to compute the propensity score were sex; age; American Society of Anesthesiologists (ASA) 
physical status; tumor location; hospital admission; neoadjuvant treatment; multidisciplinary team 
meeting; comorbidities; and clinical T (cT) and N (cN) staging. The rest of the analysis was performed using 
the matched patients by surgical approach.
We identified the variables that resulted in group imbalance according to PSM by computing the 
standardized mean difference (< 0.1), and we included them in the subsequent Cox model as covariates. 
The proportionality of risks in the Cox models was verified using Schoenfeld residuals (See Supplementary 
material). Analyses were carried out through the statistical package R (cran.r-project.org).
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Results
We included 1513 patients who underwent surgery for stage I to III rectal cancer during the study period. 
The surgical approach was laparoscopic in 933 (61.7%) patients; in 123 (13.2%) patients, laparoscopic 
surgery was converted to laparotomy.
Table 1 describes patient characteristics and therapeutic procedures by surgical approach. We first 
compared patients who underwent open surgery versus laparoscopy (including conversions to open 
surgery), and we then compared the patients receiving open surgery versus the conversion subgroup 
alone. Whether the approach was laparoscopic or open was unknown in 39 cases, which we excluded in 
PSM and consequently for the rest of the statistical analysis. After applying PSM strategy (2:1), 842 
laparoscopy and conversion patients were matched to 517 open surgery patients. (See Fig. S1. Density 
distributions of the two groups [OS vs. LS + CONV] in Supplementary material).
 Variables showing group imbalances after PSM were ASA, comorbidities and cN. (See Fig. S2 Standardized 
mean differences [SMD] between the two compared groups [OS vs. LS + CONV], Supplementary material). 
Table 2 presents the type of treatment and pathological results. 
Table 3 shows rates of first relapse and crude mortality by surgical approach.
COX models
Multivariate Cox proportional hazards regression analysis, adjusted for ASA, number of comorbidities and 
cN, revealed laparoscopy to be an independent protective factor for mortality at two years (hazard ratio 
[HR] 0.65, 95% confidence interval [CI] 0.48, 0.87) and five years (HR 0.61, 95% CI 0.50, 0.75) (Table 4, Fig. 
1) as well as for locoregional relapse at two years (HR 0.44, 95% CI 0.27, 0.72).
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Discussion 
The present study describes the characteristics of laparoscopic surgery in rectal cancer in Catalonia (Spain) 
and its benefits for locoregional recurrence and mortality compared to open surgery. To our knowledge, 
there are few reports of long-term mortality results in laparoscopic surgery for rectal cancer. 
With regard to the ongoing debate on the benefits of laparoscopy in rectal cancer beyond the immediate 
postoperative period (in our study, this technique shortened hospital stay by two days compared with 
open surgery), our results provide further evidence supporting its use as a standard surgical approach in 
rectal cancer. We observed a better prognosis in patients who received laparoscopic surgery after 
adjusting for the main prognostic factors of rectal cancer. In this regard, the European multi-institutional 
COLOR II and the COREAN randomized controlled trials (RCTs) found an oncological equivalence between 
laparoscopic and open rectal cancer resection in terms of locoregional recurrence and disease-free survival 
three years after index surgery [15,16]. However, a subgroup analysis in the COLOR II trial found 
significantly lower three-year locoregional recurrence in patients with lower rectal cancer undergoing 
laparoscopic surgery, both in the intention-to-treat and per-protocol analyses, an observation confirmed 
by our results [16]. Moreover, although the rates of disease-free survival were similar in patients with 
stage I and II rectal cancer, in patients with stage III disease, the rate of disease-free survival was 64.9% in 
the laparoscopic surgery group and 52.0% in the open surgery group (difference 12.9 percentage points; 
95% CI, 2.2 to 23.6). Lacy et al. reported similar findings in patients who underwent laparoscopic resection 
of stage III colon cancers [24]. Also, a pooled analysis of 3 RCTs comparing long-term oncological outcomes 
of laparoscopic versus open surgery for rectal cancer found no differences in locoregional recurrence or 
overall survival at 10 years. However, there was a trend toward lower recurrence at 10 years in the 
laparoscopic group compared to the open group in patients with stage III cancer (P=0.078).[25] The results 
of these analyses suggest that the oncological advantage of laparoscopic surgery may only be evident in 
studies with a large number of patients operated by experienced surgeons. The centralization of rectal 
cancer surgery in Catalonia and the implementation of the laparoscopic approach for total mesorectal 
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excision more than 10 years ago might maximize the potential oncological benefits of minimally invasive 
surgery, as we have observed in the present population-based study. 
In contrast, our results are inconsistent with those reported in the ACOSOG and the ALaCaRT studies, two 
recent multicenter RCTs that compared laparoscopic versus open surgery in rectal cancer, assessing a 
composite pathological outcome (quality of the mesorectal specimen, the completeness of tumor-free 
circumferential, and distal resection margins) [26,27]. Both trials showed a higher success rate for open 
surgery; nevertheless, the validity of the composite endpoint has not yet been demonstrated, and the 
trialists did not take the non-inferiority margin into account in the clinical interpretation of their findings. 
However, no differences for recurrence or overall survival at 2 years have been identified.[28] 
Furthermore, in the UK MRC CLASICC trial, a slightly higher, but not statistically significant, circumferential 
resection margin (CRM) positivity did not translate into any detectable difference between laparoscopic 
and open anal resection in terms of overall survival, disease-free survival, or local recurrence at three-year 
follow-up [29]. Further analysis confirmed the absence of difference at five years [30].  Moreover, a recent 
meta-analysis has demonstrated only small differences between the two approaches in terms of the 
quality of mesorectal excision [31]. In our study the differences detected in the completeness of the 
excised mesorectum are consistent with those observed in locoregional recurrence rates at two years. 
However, some caution is warranted when interpreting this result, as 14% of the values were missing. As in 
the COLOR II trial, we did not identify statistically significant differences in CRM involvement. In a recently 
published study, open surgery was found to be a risk factor for positive CRM, in contrast with the ALACART 
and ACOSOG results [32]. 
The lower local recurrence and long-term mortality in patients undergoing laparoscopic rectal excision 
cannot be explained by differences in the quality of surgery because early pathological outcomes were 
similar between groups. It is well known that open surgery leads to a greater inflammatory response than 
laparoscopy, and amplification of postoperative inflammation has been associated with poor outcomes 
after curative resection in patients with colorectal cancer [33]. Although no causal relationship has been 
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definitively established, several preclinical and clinical studies have provided direct evidence supporting 
that soluble factors released by the inflammatory response might facilitate the survival and growth of 
residual tumor cells in their path to recurrence. It is plausible that a combination of mechanisms such as 
increased angiogenesis [34], impaired immune function [35], and induction of an epithelial-to-
mesenchymal transition traits [36] as a result of surgery-induced inflammation might be responsible for 
the differences observed in the long-term outcomes between open and laparoscopic surgery. 
Regarding population-based studies, Kolfschoten et al. compared laparoscopic and open surgery in 7350 
patients with colorectal cancer, observing a significantly lower risk of in-hospital mortality, major 
morbidity, prolonged hospital stay and no radical resection in the laparoscopic surgery group [9]. To our 
knowledge there are only two other published population-based studies on the same topic with long 
follow-up.[12,13] Both obtained better long-term results in the laparoscopic group compared to the open 
surgery group.  In a population-based study from New South Wales (Australia) including  6970 surgical 
procedures, with a median follow-up of 6 years, Dobbins et al. reported that those in the laparoscopic 
group had better cancer-specific survival outcomes that the open surgery group (5-year mortality rate 27.3 
vs 29.3; adjusted HR 0.71, 95% CI 0.51, 1.00). [12] Draeger et al. also analyzed the long-term results of a 
population-based study in rectal cancer patients treated with open surgery versus laparoscopy in a 
southern German region (n= 1507).[13] After 5 years, 80.4% of laparoscopy patients were still alive 
compared to 68.6% in the open surgery group (p<0.001). Laparoscopy was also associated with better local 
recurrence-free survival in the multivariable analysis, which is consistent with our results. Regarding overall 
survival, however, evidence of a benefit was weak in the multivariate model (HR 0.77, 95% CI 0.58, 1.02; 
p=0.073). 
The advantage of population-based studies and their ‘real-world data’ is that all risk groups are included. 
The benefits of laparoscopy over open surgery for patient outcomes in both the present paper and in 
previous population-based studies might be explained by a stronger effect for laparoscopy in high-risk 
patients compared to the low-risk patients selected for RCTs. McCloskey et al. already proposed this 
explanation in their case-matched cohort study on laparoscopic versus open colectomy in high-risk veteran 
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patients, reporting the safety of laparoscopy despite the common perception that laparoscopy was 
contraindicated in this group [37]. Something similar could have happened in Catalonia with rectal cancer, 
since we observed some level of selection bias favoring low-risk patients for laparoscopic surgery: this 
group was more likely to be younger than 80 years, have fewer comorbidities, present a lower ASA and be 
diagnosed at an earlier disease stage.
 Regarding the conversion rate observed in the present study (13.2%), it is very similar to that obtained in 
the population-based study by Neree et al. [20] and the meta-analysis by Arezzo et al.[11], and it is lower 
than the one reported in a Spanish prospective non-randomized study.[38] Compared to open surgery, our 
results did not show any association between conversion and mortality or recurrence (see results in the 
annex), in line with the results published by Neree et al.[20] 
As expected, our data do not show any impact on metastasis, which is consistent with the purpose of 
surgery and its role in multidisciplinary treatment.
Postoperative morbidity in our study was significantly lower in the patients undergoing laparoscopy, which 
is in line with results reported elsewhere [9,11]. However, minimally invasive surgery was associated with a 
higher proportion of intra-abdominal infectious complications and reintervention. Readers should consider 
the possible variability in recording this complication in the clinical history and in defining intra-abdominal 
infection. In fact, previous research has already described inconsistent reporting of postoperative adverse 
events, limiting accurate comparison of rates over time and between institutions [39]. With regard to 
reinterventions, it is unlikely that these were caused by serious, life-threatening complications, since the 
mortality rate at one month after surgery in the laparoscopy group is less than half that of the open 
surgery group. In this sense, research has shown that the negative impact on long-term outcome is 
primarily driven by severe postoperative infections.[40] 
The reason for selecting 2011 and 2012 as the study period was to enable the assessment of mortality at 
five years. However, it is worth underlining that this period fell during the initial implementation of the 
health policy centralizing highly specialized oncological treatments.  This policy was a response to the 
Page 12 of 28Colorectal Disease
For Peer Review Only
variability observed in the process and outcomes indicators in a clinical audit of all patients with rectal 
cancer operated in the Catalonian public system; centers that performed fewer than 11 operations 
annually obtained worse clinical results compared to those that handled more than 30 cases every year 
[19]. The patients included in our study were operated mostly in centers authorized to perform curative 
surgery for rectal cancer, fulfilling criteria of minimum volume and adequate quality.
Strengths of our study include having examined a large population-based cohort of rectal cancer patients 
and being based on an external audit by trained data managers, but it is also subject to some limitations. 
Firstly, the study is restricted to the public system. That said, the Spanish national healthcare system 
handles more than 85% of the patients undergoing rectal cancer surgery in Catalonia, which indicates both 
the high coverage of our study and the representativeness of the quality of the procedure among the study 
population. Another limitation is the study’s retrospective nature. We addressed this aspect by equipping a 
trained team of professionals with purpose-designed instruments to ensure highly accurate data collection 
from patients' medical charts. Furthermore, hospital results were individually presented to the respective 
participant hospitals, prompting the feedback necessary to validate our results. In brief, data collection and 
assessment involved all the participating hospitals and relevant professionals in order to ensure that the 
data were a true reflection of clinical practice in the study period. Another potential limitation was that the 
follow-up of locoregional recurrence was just two years; however, this is the interval when more than 70% 
of recurrences appear [41], and the better five-year survival results in the laparoscopy group should 
support a lower locoregional recurrence rate beyond two years in this group. With regard to PSM, this 
method matches only the variables introduced, that is, it reduces the selection bias for these variables. 
However, there may be residual selection bias related to variables that were not included in the PSM, such 
as those that were not available because they were not collected. In our case, the PSM included the 
variables we believe are the most significant before surgery: sex; age; ASA physical status; tumor location; 
hospital admission; neoadjuvant treatment; multidisciplinary team meeting; number of comorbidities; and 
cT and cN staging. Variables showing group imbalances after PSM (ASA, number of comorbidities and cN) 
were included in the multivariate Cox proportional hazards regression analysis for adjustment. Lastly, we 
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cannot rule out the possibility that the differences observed between laparoscopy and open surgery are 
related to the expertise of the surgeon, not just the surgical technique or the patient selection criteria. 
However, we did not collect data by the individual surgeon but only by hospital. Further research on this 
point is ongoing.
The years in which the study took place do not correspond to an introductory period for laparoscopic 
surgery in rectal cancer in the region, since more than half of the stage I–III patients (61.7%) in the public 
network were already being operated with this approach. Rather, the study period fell during a transitional 
phase between the introduction of the technique and its widespread adoption as a standard technique. In 
this sense, a recent population-based study in the Netherlands saw a dramatic rise in the use of 
laparoscopy in rectal cancer: from 49% to 89% between 2011 and 2015, which is a higher increase than 
that seen in colon cancer. It is likely that this minimally invasive technique has now also been standardized 
in Catalonia.
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Conclusion
In real-world conditions with all risk groups, laparoscopy shows lower risk for locoregional recurrence and 
long-term mortality than open surgery.
Studies using long-term follow-up of cohorts and real-world data can provide information on clinically 
relevant outcomes to supplement randomized controlled trials. 
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Tables
Table 1. Baseline characteristics by surgical approach (overall series and propensity-core matching)
Overall series Propensity-score matched pairs













Male 601 (64.4) 348 (64.3) 87 (70.7) 25 (64.1) 0.972 0.177 551 (65.4) 333 (64.4)
Female 332 (35.6) 193 (35.7) 36 (29.3) 14 (35.9) 291 (34.6) 184 (35.6)
Age (years)* 68.4 (11.3) 69.9 (11.5) 68.7 (11.1) 69.8 (11.7) 0.011d 0.284d 69.2 (11.0) 69.8 (11.5)
Age
≤ 60 246 (26.4) 121 (22.4) 30 (24.4) 11 (28.2) 0.054 0.329 202 (24.0) 118 (22.8)
61 - 70 262 (28.1) 148 (27.4) 42 (34.1) 11 (28.2) 236 (28.0) 142 (27.5)
71 - 80 305 (32.) 175 (32.3) 32 (26.0) 6 (15.4) 287 (34.1) 165 (31.9)
 > 80 118 (12.6) 97 (17.9) 19 (15.4) 11 (28.2) 117 (13.9) 92 (17.8)
Unknown 2 (0.21) 0 0 0
ASA
ASA I 65 (7) 18 (3.3) 10 (8.1) 0 <0.001 0.011 25 (3.0) 18 (3.5)
ASA II 515 (55.2) 245 (45.3) 68 (55.3) 18 (46.2) 472 (56.0) 237 (45.8)
ASA III 265 (28.4) 213 (39.4) 37 (30.1) 13 (33.3) 264 (31.4) 201 (38.9)
ASA IV 17 (1.8) 25 (4.6) 2 (1.6) 1 (2.6) 17 (2.0) 24 (4.6)
Unknown 71 (7.6) 40 (7.4) 6 (4.9) 7 (17.9) 64 (7.6) 37 (7.2)
Tumor location
Distal rectum (0 - 6 cm) 322 (34.5) 167 (30.9) 39 (31.7) 13 (33.3) 0.258 0.051 277 (32.9) 161 (31.1)
Middle rectum (7 - 11 cm) 398 (42.7) 253 (46.8) 45 (36.6) 18 (46.2) 378 (44.9) 243 (47.0)
Proximal rectum (12  - 15 cm) 213 (22.8) 121 (22.4) 39 (31.7) 8 (20.5) 187 (22.2) 113 (21.9)
Hospital admission
Emergency department 8 (0.9) 29 (5.4) 1 (0.8) 1 (2.6) <0.001 0.028 8 (1.0) 9 (1.7)
Scheduled 925 (99.1) 512 (94.6) 122 (99.2) 38 (97.4) 834 (99.0) 508 (98.3)
Neoadjuvant treatment
Yes 585 (62.7) 320 (59.1) 69 (56.1) 22 (56.4) 0.177 0.535 524 (62.2) 310 (60.0)
No 348 (37.3) 221 (40.9) 54 (43.9) 17 (43.6) 318 (37.8) 207 (40.0)
MDT meeting
Yes 579 (62.1) 376 (69.5) 93 (75.6) 19 (48.7) <0.001 0.179 284 (33.7) 161 (31.1)
No 354 (37.9) 165 (30.5) 30 (24.4) 20 (51.3) 558 (66.3) 356 (68.9)
Number of comorbidities
0 pathologies 551 (59.1) 271 (50.1) 70 (56.9) 24 (61.5) 0.001 0.042 471 (55.9) 256 (49.5)
1 pathologies 237 (25.4) 143 (26.4) 36 (29.3) 12 (30.8) 229 (27.2) 139 (26.9)
2+ pathologies 123 (13.2) 107 (19.8) 11 (8.9) 3 (7.7) 122 (14.5) 102 (19.7)
Unknown 22 (2.3) 20 (3.7) 6 (4.9) 0 20 (2.4) 20 (3.9)
cT
T0/TiS/T1 20 (2.1) 11 (2.0) 2 (1.6) 1 (2.6) 0.142 0.228 19 (2.26) 11 (2.13)
T2 156 (16.7) 100 (18.5) 19 (15.4) 5 (12.8) 148 (17.6) 97 (18.8)
T3 580 (62.2) 319 (59.0) 67 (54.5) 25 (64.1) 516 (61.3) 308 (59.6)
T4 107 (11.5) 70 (12.9) 18 (14.6) 6 (15.4) 100 (11.9) 64 (12.4)
TX 70 (7.5) 41 (7.6) 17 (13.8) 2 (5.1) 59 (7.01) 37 (7.16)
cN
N0 307 (32.9) 181 (33.5) 42 (34.1) 9 (23.1) 0.002 0.010 282 (33.5) 174 (33.7)
N1 329 (35.3) 152 (28.1) 39 (31.7) 14 (35.9) 281 (33.4) 149 (28.8)
N2 163 (17.5) 127 (23.5) 17 (13.8) 14 (35.9) 161 (19.1) 119 (23.0)
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N+ 40 (4.3) 30 (5.5) 3 (2.4) 0 37 (4.4) 28 (5.4)
NX 94 (10.1) 51 (9.4) 22 (17.9) 2 (5.1)   81 (9.6) 47 (9.1)
ASA: American Society of Anesthesiologists physical status; CONV: conversion; LS: laparoscopy; MDT: multidisciplinary team; cT; cN (TNM 7th ed.)
Values in parentheses are percentages; values are *mean(SD).
a Comparisons between LS+CONV versus Open Surgery. 
b χ2 test
c Comparisons between CONV versus Open surgery
d T-test
p-values below 0.05 (two-sided) were considered to indicate statistical significance
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Table 2. Type of treatment received, pathologic results and postoperative variables by surgical approach (Propensity score 
matching (2:1))
  LS + CONV (n=842)
Open surgery 
(n=517) Total (n=1359) P
a
Hospital stay (days)*  11.4 (13.8) 13.3 (11.6) 12.1 (13.0) 0.008b
Type of operation Anterior resection 620 (73.6) 381 (73.7) 1001 (73.7) 0.023
Abdominoperineal resection 203 (24.1) 111 (21.5) 314 (23.1)
 Hartmann´s procedure 19 (2.2) 25 (4.8) 44 (3.2)  
Radicality R0 295 (35.0) 142 (27.5) 437 (32.2) 0.011
R1 10 (1.2) 12 (2.3) 22 (1.6)
R2 4 (0.5) 4 (0.8) 8 (0.6)
 Unknown 533 (63.3) 359 (69.4) 892 (65.6)  
M. complete 590 (70.1) 351 (67.9) 941 (69.2) 0.012
M. nearly complete 71 (8.4) 29 (5.6) 100 (7.4)
M. incomplete 83 (9.9) 48 (9.3) 131 (9.6)
Quality of mesorectal 
excision (pathology report)
Unknown 98 (11.6) 89 (17.2) 187 (13.8)  
pT pTis, pT0, pT1 162 (19.2) 84 (16.2) 246 (18.1) 0.006
pT2 232 (27.6) 146 (28.2) 378 (27.8)
pT3 386 (45.9) 218 (42.2) 604 (44.4)
pT4 50 (5.9) 57 (11.0) 107 (7.9)
 pTX 12 (1.4) 12 (2.3) 24 (1.8)  
Negative 758 (90.0) 456 (88.2) 1214 (89.3) 0.266
Positive 45 (5.3) 39 (7.5) 84 (6.2)
Not assessed 19 (2.3) 14 (2.7) 33 (2.4)
Circumferential resection 
margin (pathology report)
Unknown 20 (2.4) 8 (1.5) 28 (2.1)  
Negative 808 (96.0) 492 (95.2) 1300 (95.7) 0.863
Positive 17 (2.0) 13 (2.5) 30 (2.2)
Not assessed 11 (1.3) 7 (1.3) 18 (1.3)
Distal margin 
(pathology report)
Unknown 6 (0.7) 5 (1.0) 11 (0.8)  
Negative 815 (96.8) 503 (97.3) 1318 (97.0) 0.594
Positive 1 (0.1) 2 (0.4) 3 (0.2)
Not assessed 17 (2.0) 7 (1.3) 24 (1.8)
Proximal margin 
(pathology report)
Unknown 9 (1.1) 5 (1.0) 14 (1.0)  
<12 298 (35.4) 177 (34.2) 475 (35.0) 0.894
≥12 523 (62.1) 326 (63.1) 849 (62.5)
Lymph nodes examined 
(pathology report)
Unknown 21 (2.5) 14 (2.7) 35 (2.5)  
None 506 (60.1) 299 (57.8) 805 (59.2) 0.042
Intra-abdominal infectious complication 110 (13.1) 51 (9.9) 161 (11.9)
Postoperative complication
No Intra-abdominal infectious complication 226 (26.8) 167 (32.3) 393 (28.9)  
Reintervention Yes 87 (10.3) 35 (6.8) 122 (9.0) 0.033
 No 755 (89.7) 482 (93.2) 1237 (91.0)  
Values in parentheses are percentages; values are *mean(SD).
a χ2 test 
b  T-Test
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Table 3. Comparison of first relapse and mortality crude rates by procedure.
 Total (n=1359) LS + CONV (n=842) Open surgery (n=517) Pa
Mortality at 1 month, No. (%) 28 (2.1) 11 (1.3) 17 (3.3) 0.022
Mortality at 3 months, No. (%) 39 (2.9) 15 (1.8) 24 (4.6) 0.004
Mortality at 2 years, No. (%) 181 (13.3) 91 (10.8) 90 (17.4) 0.001
Mortality at 5 years, No. (%) 373 (27.4) 191 (22.7) 182 (35.2) <0.001
LR relapse at 2 years, No. (%) 67 (4.93) 29 (3.44) 38 (7.35) 0.002
MTS at 2 years, No. (%) 122 (8.98) 84 (9.98) 38 (7.35) 0.122
Abbreviations: CONV: converted laparoscopy; LS: laparoscopy; LR: locoregional relapse ± synchronic metastasis ; MTS: Metastasis
 a χ2 test 
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Table 4. Multivariate Cox regression analysis of laparoscopy (LS+CONV) in rectal cancer surgery
Overall series Propensity-score matched pairs
Crude model Adjusted modela Crude model Adjusted modela
 Hazard ratio (95% CI) P  Hazard ratio (95% CI) P  Hazard ratio (95% CI) P  Hazard ratio (95% CI) P
Mortality at 2 years 0.52 ( 0.40 , 0.70 ) <0.001 0.61 ( 0.46 , 0.82 ) 0.001 0.60 ( 0.44 , 0.80 ) <0.001 0.65 ( 0.48 , 0.87 ) 0.004
Mortality at 5 years 0.54 ( 0.44 , 0.66 ) <0.001 0.60 ( 0.49 , 0.73 ) <0.001 0.58 ( 0.47 , 0.71 ) <0.001 0.61 ( 0.5 , 0.75 ) <0.001
LR relapse at 2 years 0.40 ( 0.25 , 0.64 ) <0.001 0.43 ( 0.27 , 0.70 ) 0.001 0.44 ( 0.27 , 0.72 ) 0.001 0.44 ( 0.27 , 0.72 ) 0.001
MTS at 2 years 1.29 ( 0.89 , 1.86 ) 0.179  1.18 ( 0.81 , 1.72 ) 0.402  1.28 ( 0.87 , 1.88 ) 0.202  1.25 ( 0.85 , 1.84 ) 0.263
Abbreviations: CI: confidence interval; LR: locoregional relapse ± synchronic metastasis ; MTS: Metastasis
                   a Adjusted model by ASA, Number of comorbidities and cN    
                     Reference value: open surgery
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Figure 1. Overall survival by surgical procedure
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Supplementary material
Statistical analyses: Verification of proportionality of risks in COX models
For the crude models, the test of the proportional hazards assumptions for the surgical 
approach variable yielded a chi-square value of 0.48 and a p-value of 0.488 for death 
at two years, a chi-square value of 0.033 and a p-value of 0.857 for death at five years, 
and a chi-square value of 2.048 and a p-value of 0.152 for locoregional recurrence at 
two years. Thus, we can assume a proportional hazards scenario in each case. For the 
adjusted models, the test of proportional hazards assumptions for the variable surgical 
approach yielded a chi-square value of 0.079 and a p-value of 0.779 for death at two 
years, a chi-square value of 0.048 and a p-value of 0.827 for death at five years, and a 
chi-square value of 1.706 and a p-value of 0.191 for locoregional recurrence at two 
years. Again, we can also assume a proportional hazards scenario in each case.
Figure S1. Density distributions of PSM
In figure S1 we can observe the density distributions of the two groups: there is a good 
overlap between the propensity scores of the two groups, showing that most patients 
can be matched. In fact, only 24 cases in the open surgery group could not be 
matched.
Figure S2. Standardized mean differences between open surgery and laparoscopic 
surgery in the whole series and after PSM.
In Figure S2 we can observe standardized mean differences (SMD) between the two 
compared groups (OS ; LS + CONV) with the overall series (red line) and after the PSM 
(blue line): imbalance has been reduced in all variables achieving an  SMD of 0 to 0.1 
except for the variables ASA, number of comorbidities, and cN, which still show 
imbalance. These three variables have been included in the multivariate Cox 
proportional hazards regression analysis for adjustment.
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Background/rationale 2 Explain the scientific background and rationale for the investigation being reported Fulfilled 3
Objectives 3 State specific objectives, including any prespecified hypotheses Fulfilled 4
Study design 4 Present key elements of study design early in the paper Fulfilled 5
Setting 5
Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and 
data collection
Fulfilled 5-6
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comparability of assessment methods if there is more than one group
Fulfilled 5
Bias 9 Describe any efforts to address potential sources of bias Fulfilled 5
Study size 10 Explain how the study size was arrived at Fulfilled
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This is a population-based study: "multicenter retrospective cohort study of all rectal cancer patients who were 
surgically treated for the first time with curative intent in public hospitals of Catalonia in 2011 and 2012"
Quantitative variables 11




. "The main variable of interest in this the study was surgical approach (laparoscopic versus open surgery). 
Comparisons between the two groups followed the intention-to-treat principle by including converted resections in 
the laparoscopic group
9,13,14   
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(d ) If applicable, explain how loss to follow-up was addressed Not applicable
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